L

LENZ Therapeutics
D

LENZ

4.71000
USD
0.06
(1.18%)
مفتوح الان
حجم التداول
5,794
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
147,989,816
المقالات
المزيد

العنوان: LENZ Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.